ADNEURIS THERAPEUTICS GRANTS EXCLUSIVE LICENSE TO ZHEJIANG CONBA PHARMACEUTICAL TO ADVANCE CEBRANOPADOL IN GREATER CHINA

Reuters · 1d ago

Please log in to view news